Table 1 Association of the relative expression of microRNA-122 (miR-122) and clinicopathological features in cholangiocarcinoma (CC) patients.
Indexes | Cases | Relative expression | t | P |
|---|---|---|---|---|
of miR-122 | ||||
(2−ΔΔCt) | ||||
Gender | ||||
male | 30 | 0.452 ± 0.051 | ||
female | 27 | 0.430 ± 0.049 | 1.657 | 0.103 |
Age (years) | ||||
≤65 | 24 | 0.432 ± 0.044 | ||
>65 | 33 | 0.449 ± 0.055 | 1.250 | 0.217 |
Tumor size (cm) | ||||
≤5 | 31 | 0.448 ± 0.048 | ||
>5 | 26 | 0.433 ± 0.048 | 1.175 | 0.245 |
Histological grade | ||||
well-moderate | 33 | 0.452 ± 0.052 | ||
low | 24 | 0.429 ± 0.048 | 1.702 | 0.094 |
Lymph node metastasis | ||||
with | 22 | 0.392 ± 0.023 | ||
without | 35 | 0.473 ± 0.037 | 9.195 | <0.001 |
Distant metastasis | ||||
with | 9 | 0.369 ± 0.017 | ||
without | 48 | 0.456 ± 0.043 | 5.947 | <0.001 |
TNM stage | ||||
I–II | 38 | 0.446 ± 0.050 | ||
III–IV | 19 | 0.434 ± 0.053 | 0.837 | 0.406 |